The UK NICE is recommending rituximab for use on the NHS in England and Wales , meaning that patients with a common form of leukaemia could soon get approved access to the treatment. NICE has recently published a Final Appraisal Determinant recommending rituximab, but only alongside fludarabine ...
Itispossibleto achieve long-term disease control after treatment for low-grade non-Hodgkin lymphoma. Regular follow-up appointments allow your medical team to spot any signs of lymphoma returning or worsening and to begin treatment as soon as it is needed. ...